Planning and Evaluation for UCR–City of Hope Cancer Center Partnership
Official title: Planning & Evaluation
Funded at University of California Riverside · NIH-11411329 · Data updated 2026-11-12
A planning and evaluation core supports a cancer center partnership to build capacity, education, and translational resources for advancing cancer research and drug development.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project start | September 22, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $222,569 |
| NIH project number | 5U54CA285114-04 |
| Project ID | NIH-11411329 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable in the traditional sense; this is a planning/evaluation grant. Patients may benefit indirectly through improved research capacity and future translational opportunities.
✕Less likely to help
Direct patient benefits are not the focus of this core; outcomes are measures and processes rather than patient-level interventions.
What this research studies
This grant funds a Planning and Evaluation Core to monitor progress, track milestones, and guide decision-making for the UCR–City of Hope Comprehensive Cancer Center partnership. It emphasizes structured reviews, advisory boards, and feedback to leadership to prioritize projects and measure success. The focus is on building collaborations, training, and translational resources across the cancer drug development pipeline. The work will inform how the partnership grows and ensures measurable impact on cancer research capacity.
Why it matters
Potential benefit: Improved organization, prioritization, and evaluation of cancer research activities could accelerate progress toward better treatments for cancer patients.
How similar studies have gone: Similar U54 planning and evaluation cores have helped large cancer centers align goals and optimize research pipelines.
Where this research is happening
-
University of California Riverside
Riverside, United States Active
Researchers
- Principal investigator: Davis, Kendrick — University of California Riverside
- Study coordinator: Davis, Kendrick
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.